APA Alıntı

Heilmann, A. M., Perera, R. M., Ecker, V., Nicolay, B. N., Bardeesy, N., Benes, C. H., & Dyson, N. J. (2014). CDK4/6 and IGF1 receptor inhibitors synergize to suppress the growth of p16INK4A-deficient pancreatic cancers.

Chicago Stili Alıntı

Heilmann, Andreas M., Rushika M. Perera, Veronika Ecker, Brandon N. Nicolay, Nabeel Bardeesy, Cyril H. Benes, ve Nicholas J. Dyson. CDK4/6 and IGF1 Receptor Inhibitors Synergize to Suppress the Growth of P16INK4A-deficient Pancreatic Cancers. 2014.

MLA Alıntı

Heilmann, Andreas M., et al. CDK4/6 and IGF1 Receptor Inhibitors Synergize to Suppress the Growth of P16INK4A-deficient Pancreatic Cancers. 2014.